Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application

Tumori

Volumn 98, Issue 6, 2012, Pages 792-799

  Wang, Yanan ^a,b   Shi, Jinfang ^a   Wu, Yuanjian ^b   Xu, Weidong ^b   Wang, Qinxi ^c   Zhang, Jing ^a   Jiang, Min ^a   Gu, Guohao ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Shanghai Tellgen Life Science Co Ltd   (China)

Author keywords

microRNA; miRNA; NSCLC; xMAP bead based suspension array

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 145; MICRORNA 191; MICRORNA 20A; MICRORNA 21; MICRORNA 222; MICRORNA 31; MICRORNA 40; OLIGORIBONUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEAD BASED SUSPENSION ARRAY; BIOASSAY; CANCER GROWTH; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ESSENTIAL; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE PROBES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84873678163     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1217.13505     Document Type: Article

References (21)

1. Esquela-Kerscher A, Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6: 259-269, 2006.
2. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E: Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120: 21-24, 2005.
3. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP: Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. J Clin Oncol, 16: 651-657, 1998.
4. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES: Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem, 54: 1696-1704, 2008.
5. Eder M, Scherr M: MicroRNA and lung cancer. N Engl J Med, 352: 2446-2448, 2005.
6. Hammond SM: MicroRNAs as oncogenes. Curr Opin Gen Dev, 16: 4-9, 2006.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D: MicroRNA expression profiles classify human cancers. Nature, 435: 834-838, 2005.
8. Dunbar SA: Applications of LuminexR xMAPi technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta, 363: 71-82, 2006.
9. Peltier HJ, Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA, 4: 844-852, 2008.
10. López-Campos GH, Romera-López A, Martín- Sánchez F, Diaz-Rubio E, López-Alomso V, Pérez-Villamil B: MicroRNA microarray data analysis in colon cancer: effects of normalization. Lecture Notes in Computer Science, 6692: 260-267, 2011.
11. Wang H, Shi J, Wu Y, Xu W, Jiang M, Gu G: A study of the expression of microRNA in non-small cell lung cancer tissues and its clinical application. Chinese Journal of Clinical Laboratory Science, 29: 516-519, 2011.
12. Yu SL, Chen HY, Yang PC, Chen JJ: Unique MicroRNA sig- nature and clinical outcome of cancers. DNA Cell Biol, 26: 283-292, 2007.
13. Cummins JM, Velculescu VE: Implications of micro-RNA profiling for cancer diagnosis. Oncogene, 25: 6220-6227, 2006.
14. Taylor JD, Briley D, Nguyen Q, Long K, Iannone MA, Li MS, Ye F, Afshari A, Lai E, Wagner M, Chen J, Weiner MP: Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques, 30: 661-666, 2001.
15. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S: MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65: 7065-7070, 2005.
16. Chan SH, Wu CW, Li AF, Chi CW, Lin WC: MiR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res, 28: 907-911, 2008.
17. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133: 647-658, 2007.
18. Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res, 3: 6031-6043, 2007.
19. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S: A polycistronic microRNAcluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res, 65: 9628-9632, 2005.
20. Msahiro S, Akiteru G, Tetsuya O, Elise D. B, Aaron J. S, Izumi H: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. PNAS, 106: 12085-12090, 2009.
21. Biscontin A, Casara S, Cagnin S, Tombolan L, Rosolen A, Lanfranchi G, De Pittà C: New miRNA labeling method for bead-based quantification. BMC Mol Biol, 11: 44, 2010.